Final Progression-Free Survival Analyses for Lanreotide Autogel/Depot 120 mg in Metastatic Enteropancreatic Neuroendocrine Tumors: The CLARINET Extension Study
Wolin EM, Pavel ME, Cwikla JB, Phan AT, Raderer M, Sedlackova E, Cadiot G, Capdevila J, Wall L, Rindi G, Lombard-Bohas C, Liyanage N, Thanh XMT, Ruszniewski PB, Caplin ME (2018)
Publication Type: Conference contribution
Publication year: 2018
Journal
Book Volume: 47
Pages Range: 358-359
Journal Issue: 3
DOI: 10.1200/jco.2017.35.15_suppl.4089
Authors with CRIS profile
Involved external institutions
University of Warmia and Mazury in Olsztyn
Poland (PL)
Robert Debré Hospital for Mothers and Children / Hôpital Robert Debré pour la mère et l'enfant
France (FR)
Univerzita Karlova v Praze / Charles University in Prague
Czech Republic (CZ)
Montefiore Medical Center
United States (USA) (US)
Beaujon Hospital / Hôpital Beaujon
France (FR)
Cancer Treatment Centers of America
United States (USA) (US)
Centre Hospitalier Universitaire de Montpellier (CHU/CHRU MTP)
France (FR)
Ipsen Pharma
France (FR)
Royal Free Hospital
United Kingdom (GB)
Hospices Civils de Lyon (CHU)
France (FR)
Catholic University of the Sacred Heart / Università Cattolica del Sacro Cuore
Italy (IT)
Western General Hospital
United Kingdom (GB)
Vall d'Hebron University Hospital / Hospital Universitari Vall d'Hebron
Spain (ES)
Poland (PL)
Robert Debré Hospital for Mothers and Children / Hôpital Robert Debré pour la mère et l'enfant
France (FR)
Univerzita Karlova v Praze / Charles University in Prague
Czech Republic (CZ)
Montefiore Medical Center
United States (USA) (US)
Beaujon Hospital / Hôpital Beaujon
France (FR)
Cancer Treatment Centers of America
United States (USA) (US)
Centre Hospitalier Universitaire de Montpellier (CHU/CHRU MTP)
France (FR)
Ipsen Pharma
France (FR)
Royal Free Hospital
United Kingdom (GB)
Hospices Civils de Lyon (CHU)
France (FR)
Catholic University of the Sacred Heart / Università Cattolica del Sacro Cuore
Italy (IT)
Western General Hospital
United Kingdom (GB)
Vall d'Hebron University Hospital / Hospital Universitari Vall d'Hebron
Spain (ES)
How to cite
APA:
Wolin, E.M., Pavel, M.E., Cwikla, J.B., Phan, A.T., Raderer, M., Sedlackova, E.,... Caplin, M.E. (2018). Final Progression-Free Survival Analyses for Lanreotide Autogel/Depot 120 mg in Metastatic Enteropancreatic Neuroendocrine Tumors: The CLARINET Extension Study. (pp. 358-359).
MLA:
Wolin, Edward M., et al. "Final Progression-Free Survival Analyses for Lanreotide Autogel/Depot 120 mg in Metastatic Enteropancreatic Neuroendocrine Tumors: The CLARINET Extension Study." 2018. 358-359.
BibTeX: Download